Sort
21,453 grants matching “tuberculosis”
MIDAS Center for Communicable Disease Dynamics
$3,231,697Marc Lipsitch · Harvard School Of Public Health · U54 · FY2009 · GM
HIV, TB, and Malaria Vaccine Development for Africa
$3,219,459Duke University · P01 · FY2005 · AI
Medical Education Partnership Initiative in Nigeria
$3,215,832David Olufemi Olaleye · College Of Medicine, University Of Ibadan · R24 · FY2013 · TW
Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)
$3,214,086Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health · UM1 · FY2025 · AI
UZCHS CTU
$3,210,348Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2017 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$3,197,781Ann R Falsey · University Of Rochester · UM1 · FY2021 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$3,196,577Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Regional Biocontainment Laboratory (RBL) Upgrade for Colorado State University (CSU)
$3,193,195Karen Marie Dobos · Colorado State University · G20 · FY2022 · AI
Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck
$3,188,803Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
$3,188,023Linda-Gail Bekker · University Of Cape Town · UM1 · FY2025 · AI
Host and Microbial risk factors for drug-sensitive and resistant tuberculosis
$3,186,367Mercedes C Becerra · Brigham And Women'S Hospital · U19 · FY2011 · AI
Vaccine and Treatment Evaluation Units
$3,175,510Nadine Georges Rouphael · Emory University · UM1 · FY2022 · AI
The Universidade Eduardo Mondlane/UCSD Medical Education Partnership
$3,168,334Emilia Virginia Noormahomed · Eduardo Mondlane University · R24 · FY2013 · TW
Emory-CDC CTU
$3,165,957Jeffrey Lennox · Emory University · UM1 · FY2022 · AI
Bronchiectasis and chronic airway infection
$3,164,321Kevin Fennelly · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)
$3,159,329Jessica L Castilho · Vanderbilt University Medical Center · U01 · FY2023 · AI
Johns Hopkins University Kampala-Nanning Clinical Trial Unit
$3,150,635Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2014 · AI
Tuberculosis Imaging Program
$3,147,878Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Macrophage senescence as a driver of granuloma failure and progression to necrosis in TB and TB/HIV
$3,145,850William Ramses Bishai · Johns Hopkins University · R01 · FY2025 · AI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$3,143,754Jerrold J. Ellner · Boston Medical Center · U19 · FY2014 · AI
Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)
$3,135,682Catherine C McGowan · Vanderbilt University Medical Center · U01 · FY2022 · AI
Emory-CDC CTU
$3,134,849Jeffrey Lennox · Emory University · UM1 · FY2021 · AI
Bronchiectasis and chronic airway infection
$3,130,338Kenneth Olivier · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Case Clinical Trials Unit
$3,112,121Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2020 · AI
Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TB
$3,109,945Carole D Mitnick · Harvard Medical School · U01 · FY2011 · AI